Advertisement
News
Advertisement

FDA abandons off-label marketing protection ruling

Thu, 01/24/2013 - 4:02pm
Mass Device

Federal officials decide not to appeal a recent court decision that protected a salesman's off-label marketing activities as free speech.

FDA logo

Government officials decided this week not to pursue appeal of a judge's decision to protect a salesman's off-label activities as part of his right to free speech, a ruling that may put a kink in the FDA's efforts to curtail inappropriate medical device and drug marketing.

A New York court late last year overturned a lower court's ruling against Alfred Caronia, who was convicted in 2009 for illegally marketing narcolepsy drug Xyrem for uses that weren't approved by the FDA.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading